{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:39:14Z","timestamp":1791319154129,"version":"4.3.1"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/crd.0000000000000048","type":"journal-article","created":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T12:33:32Z","timestamp":1417091612000},"page":"312-316","source":"Crossref","is-referenced-by-count":17,"title":["The Heartbreak of Psoriasis"],"prefix":"10.1097","volume":"23","author":[{"given":"Max M.","family":"Benson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210203","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis.","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"R2-6-20210203","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaad.2004.07.045","article-title":"The prevalence of psoriasis in African Americans: results from a population-based study.","volume":"52","author":"Gelfand","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R3-6-20210203","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/17469872.1.1.63","article-title":"Epidemiology of psoriasis.","volume":"1","author":"Neimann","year":"2006","journal-title":"Expert Rev Dermatol"},{"key":"R4-6-20210203","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0190-9622(85)70188-0","article-title":"Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris.","volume":"13","author":"Henseler","year":"1985","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 2","key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1136\/ard.2004.033217","article-title":"Psoriasis: epidemiology, clinical features, and quality of life.","volume":"64","author":"Langley","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R6-6-20210203","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000247341","article-title":"Bimodality in age of onset of psoriasis, in both patients and their relatives.","volume":"186","author":"Smith","year":"1993","journal-title":"Dermatology"},{"key":"R7-6-20210203","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1067\/mjd.2002.119669","article-title":"The direct cost of care for psoriasis and psoriatic arthritis in the United States.","volume":"46","author":"Javitz","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R8-6-20210203","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000093848","article-title":"Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis.","volume":"213","author":"Schmitt","year":"2006","journal-title":"Dermatology"},{"key":"R9-6-20210203","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R11-6-20210203","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R12-6-20210203","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis.","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"R13-6-20210203","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1087-0024.2003.09110.x","article-title":"Quality of life in patients with psoriasis: a systematic literature review.","volume":"9","author":"de Korte","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"R14-6-20210203","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2133.1978.tb02012.x","article-title":"Psoriasis and occlusive vascular disease.","volume":"99","author":"McDonald","year":"1978","journal-title":"Br J Dermatol"},{"key":"R15-6-20210203","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaad.2008.01.006","article-title":"National Psoriasis Foundation. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.","volume":"58","author":"Kimball","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R16-6-20210203","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clindermatol.2007.08.006","article-title":"Comorbidities in psoriasis.","volume":"25","author":"Christophers","year":"2007","journal-title":"Clin Dermatol"},{"key":"R17-6-20210203","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis.","volume":"55","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R18-6-20210203","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.","volume":"298","author":"Sommer","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"R19-6-20210203","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis.","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"R20-6-20210203","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/eurheartj\/ehr285","article-title":"Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study.","volume":"33","author":"Ahlehoff","year":"2012","journal-title":"Eur Heart J"},{"key":"R21-6-20210203","first-page":"1196","article-title":"All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database.","volume":"30","author":"Watson","year":"2003","journal-title":"J Rheumatol"},{"key":"R22-6-20210203","first-page":"36","article-title":"Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis.","volume":"30","author":"Wolfe","year":"2003","journal-title":"J Rheumatol"},{"key":"R23-6-20210203","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","article-title":"Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.","volume":"107","author":"Solomon","year":"2003","journal-title":"Circulation"},{"key":"R24-6-20210203","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"R25-6-20210203","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/art.24537","article-title":"Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses health study.","volume":"61","author":"Hak","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R26-6-20210203","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2003.09.037","article-title":"Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction.","volume":"93","author":"Fischer","year":"2004","journal-title":"Am J Cardiol"},{"key":"R27-6-20210203","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1600-0625.2011.01308.x","article-title":"A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis.","volume":"20","author":"Armstrong","year":"2011","journal-title":"Exp Dermatol"},{"key":"R28-6-20210203","doi-asserted-by":"crossref","first-page":"965385","DOI":"10.1155\/2012\/965385","article-title":"A review of psoriasis, a known risk factor for cardiovascular disease and its impact on folate and homocysteine metabolism.","volume":"2012","author":"McDonald","year":"2012","journal-title":"J Nutr Metab"},{"key":"R29-6-20210203","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/B:EJEP.0000020447.59150.f9","article-title":"Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients.","volume":"19","author":"Mallbris","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"R30-6-20210203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/annrheumdis-2011-201194","article-title":"Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review.","volume":"72","author":"Jamnitski","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R31-6-20210203","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severity and the prevalence of major medical comorbidity: a population-based study.","volume":"149","author":"Yeung","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R32-6-20210203","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/bjd.12490","article-title":"Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta-analysis.","volume":"169","author":"Miller","year":"2013","journal-title":"Br J Dermatol"},{"key":"R33-6-20210203","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/HJH.0b013e32835bcce1","article-title":"The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies.","volume":"31","author":"Armstrong","year":"2013","journal-title":"J Hypertens"},{"key":"R34-6-20210203","first-page":"9","article-title":"Psoriasis: comorbidities and associations.","volume":"146","author":"Farley","year":"2011","journal-title":"G Ital Dermatol Venereol"},{"key":"R35-6-20210203","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1038\/nutd.2012.26","article-title":"The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies.","volume":"2","author":"Armstrong","year":"2012","journal-title":"Nutr Diabetes"},{"key":"R36-6-20210203","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/2013.jamadermatol.406","article-title":"Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis.","volume":"149","author":"Armstrong","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R37-6-20210203","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jaad.2012.04.039","article-title":"The association of psoriasis with autoimmune diseases.","volume":"67","author":"Wu","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R38-6-20210203","doi-asserted-by":"crossref","first-page":"f5961","DOI":"10.1136\/bmj.f5961","article-title":"Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study.","volume":"347","author":"Wan","year":"2013","journal-title":"BMJ"},{"key":"R39-6-20210203","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2009.04.020","article-title":"Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.","volume":"51","author":"Gisondi","year":"2009","journal-title":"J Hepatol"},{"key":"R40-6-20210203","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jhep.2009.06.008","article-title":"Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.","volume":"51","author":"Miele","year":"2009","journal-title":"J Hepatol"},{"key":"R41-6-20210203","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1365-2133.2008.08749.x","article-title":"Psoriasis and chronic obstructive pulmonary disease: a case-control study.","volume":"159","author":"Dreiher","year":"2008","journal-title":"Br J Dermatol"},{"key":"R42-6-20210203","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000121333","article-title":"Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002.","volume":"217","author":"Kimball","year":"2008","journal-title":"Dermatology"},{"key":"R43-6-20210203","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2310\/7750.2013.13052","article-title":"Risk of myocardial infarction in Canadian patients with psoriasis: a retrospective cohort study.","volume":"17","author":"Levesque","year":"2013","journal-title":"J Cutan Med Surg"},{"key":"R44-6-20210203","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.amjcard.2011.11.025","article-title":"Coronary artery disease in patients with psoriasis referred for coronary angiography.","volume":"109","author":"Armstrong","year":"2012","journal-title":"Am J Cardiol"},{"key":"R45-6-20210203","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/archdermatol.2009.94","article-title":"Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality.","volume":"145","author":"Prodanovich","year":"2009","journal-title":"Arch Dermatol"},{"key":"R46-6-20210203","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.amjmed.2009.08.022","article-title":"Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis.","volume":"123","author":"Kimball","year":"2010","journal-title":"Am J Med"},{"key":"R47-6-20210203","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis.","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"R48-6-20210203","first-page":"159","article-title":"Infections and psoriasis; a preliminary communication.","volume":"32","author":"Norholm-Pedersen","year":"1952","journal-title":"Acta Derm Venereol"},{"key":"R49-6-20210203","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1365-2249.2001.01563.x","article-title":"Skin T cell proliferative response to M protein and other cell wall and membrane proteins of group A streptococci in chronic plaque psoriasis.","volume":"124","author":"Baker","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"R50-6-20210203","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","article-title":"IL-17 family cytokines and the expanding diversity of effector T cell lineages.","volume":"25","author":"Weaver","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"R51-6-20210203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","article-title":"A brief history of TH17, the first major revision in the TH1TH2 hypothesis of T cell-mediated tissue damage.","volume":"13","author":"Steinman","year":"2007","journal-title":"Nat Med"},{"key":"R52-6-20210203","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells.","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"R53-6-20210203","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1189\/jlb.0212101","article-title":"Targeting the Th17 pathway in psoriasis.","volume":"92","author":"Elloso","year":"2012","journal-title":"J Leukoc Biol"},{"key":"R54-6-20210203","doi-asserted-by":"crossref","first-page":"e779","DOI":"10.1371\/journal.pone.0000779","article-title":"Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions.","volume":"2","author":"de Boer","year":"2007","journal-title":"PLoS One"},{"key":"R55-6-20210203","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17Treg imbalance in patients with acute coronary syndrome.","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin Immunol"},{"key":"R56-6-20210203","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000314626","article-title":"Emerging role of IL-17 in atherosclerosis.","volume":"2","author":"Chen","year":"2010","journal-title":"J Innate Immun"},{"key":"R57-6-20210203","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/CRD.0000000000000021","article-title":"Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy.","volume":"22","author":"Hartman","year":"2014","journal-title":"Cardiol Rev"},{"key":"R58-6-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2006.07.011","article-title":"Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.","volume":"190","author":"Wakkee","year":"2007","journal-title":"Atherosclerosis"},{"key":"R59-6-20210203","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1530\/eje.1.02057","article-title":"Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines.","volume":"154","author":"Corbetta","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"R60-6-20210203","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaad.2004.06.017","article-title":"Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.","volume":"52","author":"Prodanovich","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R61-6-20210203","first-page":"1","article-title":"Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis.","volume":"20","author":"Wu","year":"2012","journal-title":"Arch Dermatol"},{"key":"R62-6-20210203","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"British Society for Rheumatology Biologics Register Control Centre Consortium; British Society for Rheumatology Biologics Register. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R63-6-20210203","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/ard.2006.062497","article-title":"Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis.","volume":"66","author":"Jacobsson","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R65-6-20210203","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site.","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat Med"},{"key":"R66-6-20210203","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.","volume":"420","author":"Youssef","year":"2002","journal-title":"Nature"},{"key":"R67-6-20210203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaad.2010.05.039","article-title":"Statin use and risk of first-time psoriasis diagnosis.","volume":"65","author":"Brauchli","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R68-6-20210203","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0738-081X(98)00005-4","article-title":"Drugs in exacerbation and provocation of psoriasis.","volume":"16","author":"Tsankov","year":"1998","journal-title":"Clin Dermatol"},{"key":"R69-6-20210203","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/00015550510032823","article-title":"Drug exposure and psoriasis vulgaris: case-control and case-crossover studies.","volume":"85","author":"Cohen","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"R70-6-20210203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/000155501317140061","article-title":"Calcium channel blockers intake and psoriasis: a case-control study.","volume":"81","author":"Cohen","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"R71-6-20210203","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1001\/archderm.1981.01650010008011","article-title":"Exacerbation of psoriasis during clonidine therapy.","volume":"117","author":"Wilkin","year":"1981","journal-title":"Arch Dermatol"},{"key":"R72-6-20210203","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2133.2002.48848.x","article-title":"Sartans, angiotensin II receptor antagonists, can induce psoriasis.","volume":"147","author":"Marquart-Elbaz","year":"2002","journal-title":"Br J Dermatol"},{"key":"R73-6-20210203","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.amjcard.2010.08.016","article-title":"Usefulness of the Framingham risk score in patients with chronic psoriasis.","volume":"106","author":"Gisondi","year":"2010","journal-title":"Am J Cardiol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:27:24Z","timestamp":1747171644000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-201511000-00006"}},"subtitle":["A Review of Cardiovascular Risk in Patients With Psoriasis"],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000048","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}